Dr. Bernhard Noreisch LL.M.

Dr Bernhard Noreisch specialises in M&A, venture capital, commercial and corporate law. His clients are mainly medium-sized companies, national and international investors, family offices and young companies, which he regularly assists in M&A transactions and financing rounds.

Besides, Dr Bernhard Noreisch is characterised by his high level of personal commitment, his negotiating skills, his experience, and his solution-oriented advice. Even in highly complex projects, he convinces with competence and his sympathetic and calm manner.

• Venture capital / private equity
• Acquisition and sale of companies / M&A
• Corporate law
• Commercial and contract law

• JUVE Handbook continuously since 2016 | 2017: Leading advisor for venture capital
• JUVE Handbook continuously since 2013 | 2014: Often recommended lawyer
• Handelsblatt & Best Lawyers: One of the best lawyers for corporate law (2021-2023), venture capital (2021-2023) and private equity (2020 – 2023)
• Legal 500 Germany (& EMEA) 2016 – 2024 continuously: Recommended lawyer

• Certified specialist lawyer for commercial and corporate law since 2007
• Lawyer at LUTZ | ABEL since 2003
• Admission to the bar, 2003
• Master's degree at the University of Edinburgh
• Doctorate (Dr. jur.) and additional training in economics in Bayreuth
• Law studies in Passau and Bayreuth

• Neura Robotics on EUR 50 m financing round
• Bayern Kapital GmbH with its ScaleUp Fonds Bayern on EUR 155 m financing round of Isar Aerospace
• Majority shareholder of Locoia on sale of locoia GmbH to Aareon Group
• APK AG in EUR 130 m financing round
• MIG-Fonds on EUR 128 m series A2 financing round of IQM Finland OY
• Samsung Catalyst Fund on USD 90 m series B financing round in Ada Health GmbH, 2021
• MIG-Fonds on USD 20 m series A investment in German Bionic Systems, 2020
• AMSilk on EUR 29 m series C financing round, 2021
• Dosimetrics on trade sale to Mirion Technologies, 2020
• Wachstumsfonds Bayern 2 and Bayern Kapital Innovationsfonds II on EUR 50 m financing round in CatalYm, 2020
• MIG-Fonds on EUR 39 m financing round in IQM, 2020
• SHS on investment in Blazejewski MEDI-TECH, 2019